Utilization in COPD: Patient characteristics and diagnostic evaluation

Chest

Volumn 117, Issue 5 SUPPL. 2, 2000, Pages 346S-353S

  Mapel, Douglas W ^a,c   Picchi, Maria A ^a   Hurley, Judith S ^b   Frost, Floyd J ^b   Petersen, Hans V ^b   Mapel, Vesta M ^a   Coultas, David B ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Comorbidity; Diagnosis; Managed care programs; Obstructive lung disease; Respiratory function tests; Smoking; Utilization review

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DIAGNOSTIC TEST; FEMALE; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; SMOKING CESSATION; SPIROMETRY; UNIVERSITY HOSPITAL;

EID: 0034122996     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Peters KD, Kochanek KD, Murphy SL. Deaths: final data for 1996. National vital statistic reports 1998; 47:1-15. Hyattsville, MD: National Center for Health Statistics; Department of Health and Human Services Publication No. (PHS) 99-1120, 1998; 8-0761
2. Mannino DM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through 1993. Am J Respir Crit Care Med 1997; 156:814-818
3. Centers for Disease Control and Prevention, US Department of Health and Human Services. Current estimates from the National Health Interview Survey, 1995. Department of Health and Human Services Publication No. (PHS) 96-1527, 1998; Series 10, No. 199; 83-93
4. Coultas DB, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction [abstract]. Am J Respir Crit Care Med 1999; 159(suppl):A803
5. Verbrugge LM, Patrick DL. Seven chronic conditions: their impact on US adults' activity levels and use of medical services. Am J Public Health 1995; 85:173-182
6. Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. JAMA 1997; 277:246-253
7. The National Lung Health Education Program Committee. Strategies in preserving lung health and preventing COPD and associated diseases. Chest 1998; 113(suppl):123S-163S
8. Niederman MS. Introduction: mechanisms and management of COPD; we can do better - it's time for a re-evaluation. Chest 1998; 113(suppl):233S-234S
9. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77-S121
10. 1: The Lung Health Study. JAMA 1994; 272:1497-1505
11. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996; 154:959-967
12. Regueiro CR, Hamel MB, Davis RB, et al. A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. Am J Med 1998; 105:366-372
13. Grasso ME, Weller WE, Shaffer TJ, et al. Capitation, managed care, and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:133-138
14. Cydulka RK, McFaden ER Jr, Everman CL, et al. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary diseases. Am J Respir Crit Care Med 1997; 156:1807-1812
15. American Thoracic Society. Update: future directions for research on diseases of the lung. Am J Respir Crit Care Med 1998; 158:320-334
16. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: definitions, epidemiology, pathophysiology, diagnosis, and staging. Am J Respir Crit Care Med 1995; 15S:S78-S83
17. Ferris BG. Epidemiology standardization project. Am Rev Respir Dis 1978; 118:1-120
18. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383
19. Samet JM, Schrag SD, Howard CA, et al. Respiratory disease in a New Mexico population sample of Hispanic and nonHispanic whites. Am Rev Respir Dis 1982; 125:152-157
20. National Center for Chronic Disease Prevention and Promotion. Behavioral risk factor surveillance system 1997 survey data (computer file). Washington, DC: US Department of Health and Human Services, 1999
21. Hoffman C, Rice D, Sung HY. Persons with chronic conditions: their prevalence and costs. JAMA 1996; 276:1473-1479
22. van den Akker M, Buntinx F, Metsemakers JF, et al. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998; 51:367-375
23. Pauwels RA, Lofdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 1999; 340:1948-1953
24. US Department of Health, and Human Services. The health benefits of smoking cessation: a report of the Surgeon General. Washington, DC: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990; 103-274; Department of Health and Human Services Publication No. (CDC)90-8416
25. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340:685-691
26. Ashton CM, Petersen NJ, Souchek J, et al. Geographic variations in utilization rates in veterans affairs hospitals and clinics. N Engl J Med 1999; 340:32-39
27. Curry SJ, Grothaus LC, McAfee T, et al. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med 1998; 339:673-679